Skip to main content Back to Top


Docusate Sodium Oral Liquid in Bulk Bottles

Products Affected - Description

    • Diocto oral liquid, Geri-Care, 150 mg/15 mL, 473 mL bottle, 1 count, NDC 57896-0403-16 - discontinued
    • Diocto oral syrup, Geri-Care, 60 mg/15 mL, 473 mL bottle, 1 count, NDC 57896-0409-16 - discontinued
    • Docu Liquid oral liquid, Akorn, 150 mg/15 mL, 473 mL bottle, 1 count, NDC 50383-0771-16

Reason for the Shortage

    • Akorn has Docu Liquid on shortage because they are waiting on raw ingredients.
    • Geri-Care had a contract manufacturer shut down. The company has discontinued Diocto syrup and liquid.
    • Lannett did not provide a reason for the shortage.
    • Docusate sodium 10 mL unit dose cups are not affected.

Available Products

    • Silace oral liquid, Lannett, 150 mg/15 mL, 473 mL bottle, 1 count, NDC 54838-0116-80
    • Silace oral syrup, Lannett, 60 mg/15 mL, 473 mL bottle, 1 count, NDC 54838-0107-80

Estimated Resupply Dates

    • Akorn has Docu Liquid in 473 mL bottles on back order and the company estimates a release date of late-November 2019.
    • Geri-Care discontinued Diocto liquid in 473 mL bottles the company plans to relaunch the product in the 2nd or 3rd quarter of 2020.


Updated November 13, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created August 19, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins